Compass Therapeutics Receives FDA Fast Track Designation for the[...]
Reminder-The company's shares will be delisted from TASE on May 9 2024,[...]
New Data Show RINVOQ® (upadacitinib) Demonstrated Superiority Versus[...]
04/11/2021 | News release | Distributed by Public on 04/11/2021 09:55
Please select the service you want to use:
Smartlinks | IMF - International Monetary Fund | News | International News | Politics and Policy | Government | National Government | International Policy | International Governmental Organizations (IGO) | Business and Economy | Economy | Global Economy | International Economic Institutions | International Institutions
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact